黑色素瘤细胞和CAF之间的动态相互作用:药物耐药性和免疫逃避以及可能的治疗方法的含义
Chou-Yi Hsu1, Raed Obaid Saleh2, Jaafaru Sani Mohammed3
1Thunderbird School of Global Management, Arizona State University, Tempe Campus, Phoenix, AZ, 85004, USA.
Experimental cell research
|May 1, 2025
概括
与癌症相关的纤维细胞 (CAF) 通过塑造瘤微环境,显著影响黑色素瘤的进展和治疗耐药性. 针对CAF提供了一个有希望的策略,以改善黑色素瘤治疗结果.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 黑色素瘤带来了重大的治疗挑战,特别是在晚期.
- 癌症相关纤维细胞 (CAF) 是黑色素瘤瘤微环境 (TME) 中的关键参与者.
- CAFs表现出异质性,并有助于瘤进展,转移和免疫逃避.
研究的目的:
- 阐明黑色素瘤细胞和CAFs之间的复杂相互作用.
- 探索CAF亚型在黑色素瘤中的不同作用和起源.
- 审查针对CAF的治疗策略,以改善黑色素瘤治疗.
主要方法:
- 对黑色素瘤中CAFs现有文献的综述.
- 分析CAF异质性及其前瘤功能.
- 检查针对CAF的当前和新兴治疗方法.
主要成果:
- 通过产生细胞外基质,诱导血管生成,并赋予耐药性,CAFs促进黑色素瘤.
- CAFs通过招募免疫抑制细胞和抑制T细胞活性来抑制抗瘤免疫力.
- CAF活动与患者预后不佳有很强的相关性.
结论:
- 理解CAF亚型及其功能对于开发有效的黑色素瘤疗法至关重要.
- 向CAF具有破坏瘤支持和增强治疗反应的潜力.
- 对CAF介导免疫调节的进一步研究可以指导新的治疗干预措施.
更多相关视频
相关概念视频
The Tumor Microenvironment
6.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.4K
Adaptive Mechanisms in Cancer Cells
5.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.5K
Cancer Stem Cells and Tumor Maintenance
4.6K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.6K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Cancer Cell Migration through Invadopodia
2.2K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.2K


